Prevention of Periprocedural Stroke and Management of Hemorrhagic Complication in Atrial Fibrillation Ablation under Continuing Warfarin Administration
スポンサーリンク
概要
- 論文の詳細を見る
<B>Background:</B> This study aimed to determine the effect of continuing warfarin during periprocedural period of atrial fibrillation (AF) ablation on the prevention of stroke complication and to show a management of hemorrhagic complication in this approach. <B>Method:</B> A total of 2976 patients undergoing AF ablation (3855 sessions) were divided into two groups: the first 1953 patients (2566 sessions) discontinuing warfarin before AF ablation, given heparin and resuming warfarin after the ablation (discontinuing group) and the last 1023 patients (1289 sessions) continuing warfarin throughout the periprocedural period (continuing group). <B>Results:</B> Symptomatic stroke or transient ischemic attack occurred in 13/2566 sessions (0.51%) in the discontinuing group and in 2/1289 sessions (0.16%) in the continuing group. Two stoke patients in the latter group showed insufficient international normalized ratio (INR) of 1.23 and 1.57 before AF ablation. Major hemorrhagic complication occurred in 26/2566 (1%) in the discontinuing group and in 9/1289 (0.7%, 9 cardiac tamponade) in the continuing group. Eight of the 9 patients with cardiac tamponade in the latter group were given prothrombin complex concentrate (PCC) and vitamin K, with the INR corrected and bleeding of cardiac tamponade safely terminated. <B>Conclusion:</B> AF ablation without discontinuation of warfarin was effective to prevent periprocedural stroke complication. Bleeding of cardiac tamponade in this approach was safely terminated with the use of PCC and vitamin K.
- 日本不整脈学会の論文
著者
-
Takahashi Atsushi
Yokosuka Kyosai Hospital
-
Takahashi Yoshihide
Yokosuka Kyosai Hospital
-
Kuwahara Taishi
Yokosuka Kyosai Hospital
-
Okubo Kenji
Yokosuka Kyosai Hospital
-
Takagi Katsumasa
Yokosuka Kyosai Hospital
関連論文
- PJ-798 Clinical Characteristics of Cardiac Tamponade Complicating Catheter Ablation Therapy for Atrial Fibrillation(Arrhythmia, therapy(27)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- DPE-043 Coronary Flow Velocity Measured with TIMI Frame Count and Quantitative Angiogram Predicts Functional Recovery in TIMI3 Reperfused Acute Myocardial Infarction(DPE08,ACS/AMI (Clinical/Diagnosis) (IHD),Digital Poster Session (English),The 73rd Annual
- OE-267 Elevated C-Reactive Protein after Coronary Stent Implantation Predicts Plaque Morphology(OE45,Angina Pectoris (Clinical, Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- DPE-043 Coronary Flow Velocity Measured with TIMI Frame Count and Quantitative Angiogram Predicts Functional Recovery in TIMI3 Reperfused Acute Myocardial Infarction(DPE08,ACS/AMI (Clinical/Diagnosis) (IHD),Digital Poster Session (English),The 73rd Annual
- Association between Atrial Fibrillation and Mortality after Percutaneous Coronary Intervention
- The Long-Term Clinical Outcomes of Radiofrequency Catheter Ablation for Inducible Ventricular Tachycardia prior to Implantation of Cardioverter-Defibrillator
- Reduced Cardiac Function of Patients with Implantable Cardioverter-Defibrillator Shock; 3-Years Follow Up Study
- Radiofrequency Hot Balloon Catheter Ablation of Atrial Fibrillation: Results of a Multicenter Clinical Trial in Japan
- Long Term Results of Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients Less Than 50 Years Old
- Electrophysiological Characteristics of Successful Ablation Sites at Non-Coronary Cusp to Eliminate Adenosine-Sensitive Atrial Tachycardia
- Sinus Node Dysfunction after Catheter Ablation of Persistent Atrial Fibrillation: The Incidence and Clinical Characteristics
- Prevention of Periprocedural Stroke and Management of Hemorrhagic Complication in Atrial Fibrillation Ablation under Continuing Warfarin Administration